Format

Send to

Choose Destination
Leukemia. 2012 Jan;26(1):162-4. doi: 10.1038/leu.2011.181. Epub 2011 Aug 5.

Limited clinical activity of nilotinib and sorafenib in FIP1L1-PDGFRA positive chronic eosinophilic leukemia with imatinib-resistant T674I mutation.

PMID:
21818111
DOI:
10.1038/leu.2011.181
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center